Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-06

FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ZOMACTON (somatropin) filed by Ferring Pharmaceuticals Inc., authorizing changes to its approved use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZOMACTON (Somatropin)

Snippet

SUPPL AP for ZOMACTON (SOMATROPIN)